MedTrace Logo

UPLYFT For Lymphoma Survivors

NCT05080166 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-02-24

No results posted yet for this study

Summary

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

Conditions

Interventions

OTHER

Interview with Clinicians

One time, qualitative interview of clinicians for feedback on UPLYFT intervention

OTHER

Field Test of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors for feedback

BEHAVIORAL

Pilot of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors

Sponsors & Collaborators

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-08
Primary Completion
2026-05-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080166 on ClinicalTrials.gov